Page results
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
This is information for women who have been given a diagnosis of adenomyosis.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
Bones marrow harvest patient information page.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
Health and wellbeing information for people affected by cancer.
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
File results
-
FOI/2024/0635 - Patient incidences/ injuries due to chiropractic treatment
-
FOI/2024/0641 - Chief Nursing Information Officer (CNIO)/ chief midwifery information officer (CMIO)
-
FOI/2024/0645 - Electronic Patient Record (EPR) systems usage, expenditure, contract and digital maturity
-
FOI/2024/0646 - Management of Combine Heat and Power (CHP) units
-
FOI/2024/0647 - Treatment of rare diseases; Fabry/ Gaucher/ Pompe disease
-
FOI/2024/0650 - Framework used for Radiology Information System (RIS)
-
FOI/2024/0653 - Sterile services/ decontamination units
-
FOI/2024/0659 - Treatment of cancers; breast/ prostate/ ovarian and endometrial
-
FOI/2024/0660 - Bariatric patient equipment spend/ contract/ supplier
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma